Navigation Links
Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
Date:1/4/2008

m heart attacks annually in the U.S.(iii)

About prasugrel

Daiichi Sankyo Company, Limited (TSE: 4568), and Eli Lilly and Company (NYSE: LLY) are co-developing prasugrel, an investigational oral antiplatelet agent invented by Daiichi Sankyo and its Japanese research partner Ube Industries, Ltd., as a potential treatment, initially for patients with acute coronary syndrome who are managed with PCI. Prasugrel works by inhibiting platelet activation and subsequent aggregation by blocking the P2Y12 adenosine diphosphate (ADP) receptor on the platelet surface. Antiplatelet agents prevent platelets from clumping or sticking together, which can result in clogged arteries and may lead to heart attack or stroke.

About Daiichi Sankyo Company, Limited

Daiichi Sankyo Company, Limited, established in 2005 after the merger of two leading century-old Japanese pharmaceutical companies, is a global pharmaceutical innovator, continuously generating innovative drugs that enrich the quality of life for patients around the world. The company uses its cumulative knowledge and expertise in the fields of cardiovascular disease, cancer, metabolic disorders, and infection as a foundation for developing an abundant product lineup and R&D pipeline.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first in class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

This press release contains certain f
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related biology technology :

1. DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin
2. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
3. Lilly Declares Fourth-Quarter Dividend
4. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
5. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
6. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
7. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
9. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
10. AMDL Submits Data to FDA for Clearance to Market Its DR-70(R) Diagnostic Test to Monitor Colorectal Cancer Patients
11. Cephalon Submits Supplemental New Drug Application for FENTORA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... PHARMACEUTICALS, INC. (OTC Bulletin Board: ... launch of MuGard, an FDA approved treatment for oral ... chemotherapy. MuGard is commercially launched by Access, partner, SpePharm, ... Norway, Greece and Sweden. Access is conducting pre-marketing activities, ...
(Date:12/3/2009)... Medical Innovations, Inc. (NYSE: IMA ), a global ... at home through the merger of rapid diagnostics and health ... its Series B Convertible Perpetual Preferred Stock ( IMA-PB). The ... in an amount per share equal to the quotient of ...
(Date:12/2/2009)... Philippines, Dec. 2 Spectrum Blue Steel is emerging as ... planet. Through the efforts of True Green Energy Group and ... has been in the recycling business for over 25 years, ... everyone and is setting the stage for spectacular earnings because ...
(Date:12/2/2009)... Nearly 600 medical research executives, scientists, policy makers, ... and innovative funding strategies at the inaugural Partnering ... the Washington-based center of the Milken Institute, convened ... to turn a scientific discovery into an accessible therapy. ...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
... June 19 deCODE genetics,(Nasdaq: DCGN ) today ... deCODE,CEO Kari Stefansson,s presentation at the Piper Jaffray Europe ... June 25, at 7am,Eastern Time/11am GMT/12 noon British Summer ... be accessed through the Investors page on deCODE,s,website, ...
... on Friday, June 20, 2008, NEW YORK, June ... plaintiffs, litigation law firms in America, filed a lawsuit ... York City Fire,Department Emergency Medical Technician whose diabetes was ... Armstead, was one,of the many brave responders on the ...
... TRIANGLE PARK, N.C., June 19 Quintiles,Transnational Corp. ... Global,Marketing and Chief Marketing Officer and David Coman ... Patient Recruitment., "Both Dave and Millie bring ... in marketing and communication," said Mike Mortimer,Chief Administrative ...
Other Biology Technology:deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference 2deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference 3Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca 2Quintiles Appoints New Executives 2
(Date:12/3/2009)... year, the CTRC-AACR San Antonio Breast Cancer Symposium continues ... world leaders from industry and academia with the goal ... than 8,500 scientists and other professionals will gather at ... from Dec. 9-13, 2009. The symposium is a partnership ...
(Date:12/3/2009)... Mich. (Dec. 3, 2009) Van Andel Research ... abscisic acid (ABA) works at the molecular level to help ... Their findings, published in the journal Nature , ... the world and combat global food shortages. The findings ...
(Date:12/3/2009)... by a social snubbing? Your genetics, not your friends, may ... painkillers, called opioids, relieve not only physical pain, but also ... by Faculty of 1000 Biology member Markus Heilig shows that ... can determine the intensity of people,s responses to social rejection. ...
Breaking Biology News(10 mins):CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 321 Regional Hospitals Recognized as Nations Most Wired 50941 121 Regional Hospitals Recognized as Nations Most Wired 50941 221 Regional Hospitals Recognized as Nations Most Wired 50941 3Knowing Yourself Can Improve Your Health and Happiness 50937 1Knowing Yourself Can Improve Your Health and Happiness 50937 2Knowing Yourself Can Improve Your Health and Happiness 50937 3Family History Key to Psychiatric Disorder Risk 50934 1Family History Key to Psychiatric Disorder Risk 50934 2
... been awarded 5 million to investigate how cells respond to ... at Liverpool will investigate the role of the NF-kappaB signalling ... NFkB governs responses within cells to stimuli such as stress ... it is thought that it can lead to cancer, inflammatory ...
... Studies of the birth and incorporation of ... as adult neurogenesispromise intriguing insights into the mechanisms of ... and other psychiatric disorders. A new book from ... to define this relatively young field. , Adult ...
... 2007. A ten-week expedition to the Lazarev Sea and ... year,s Antarctic research season of the German research vessel ... two hours after an official ceremony at the Berlin ... service, the research vessel will begin its 24th scientific ...
Other Biology News:New book defines promising young field of adult neurogenesis 2Climate change and life in the Southern Ocean 2Climate change and life in the Southern Ocean 3Climate change and life in the Southern Ocean 4